Group-level disorder | Count | Prevalence (%) | Female prevalence (%) | Male prevalence (%) | P-value* | Median age (years) of dogs with the condition |
---|---|---|---|---|---|---|
Ophthalmologic | 426 | 22.27 (20.40 - 24.13) | 23.42 | 21.14 | 0.255 | 1.53 |
Dermatological | 402 | 21.01 (19.19 - 22.84) | 20.52 | 21.45 | 0.656 | 2.61 |
Aural | 357 | 18.66 (16.92 - 20.41) | 19.44 | 17.88 | 0.412 | 2.80 |
Traumatic injury | 144 | 7.53 (6.35 - 8.71) | 7.95 | 7.15 | 0.566 | 3.10 |
Behavioural | 138 | 7.21 (6.05 - 8.37) | 4.08 | 10.21 | <  0.001 | 3.36 |
Enteropathy | 123 | 6.43 (5.33 - 7.53) | 5.48 | 7.35 | 0.115 | 2.89 |
Mass associated | 76 | 3.97 (3.10 - 4.85) | 3.76 | 4.19 | 0.717 | 4.96 |
Musculoskeletal | 72 | 3.76 (2.91 - 4.62) | 4.08 | 3.47 | 0.563 | 3.44 |
Shar Pei Fever | 58 | 3.03 (2.26 - 3.80) | 2.90 | 3.17 | 0.837 | 4.45 |
Claw disorder | 48 | 2.51 (1.81 - 3.21) | 2.90 | 2.15 | 0.364 | 3.54 |
Parasitic | 48 | 2.51 (1.81 - 3.21) | 3.11 | 1.94 | 0.136 | 1.29 |
Upper respiratory tract | 37 | 1.93 (1.32 - 2.55) | 1.93 | 1.94 | 0.999 | 1.30 |
Lethargy | 36 | 1.88 (1.27 - 2.49) | 1.93 | 1.84 | 0.999 | 3.08 |
Female reproductive (females only) | 35 | 1.83 (1.23 - 2.43) | 3.76 | – | – | 2.11 |
Neoplasia | 33 | 1.73 (1.14 - 2.31) | 2.04 | 1.43 | 0.396 | 8.00 |
Dental | 31 | 1.62 (1.05 - 2.19) | 1.61 | 1.63 | 0.999 | 6.61 |
Hernia | 30 | 1.57 (1.01 - 2.12) | 1.40 | 1.74 | 0.679 | 1.05 |
Complication associated with clinical care | 19 | 0.99 (0.55 - 1.44) | 1.29 | 0.72 | 0.302 | 2.18 |
Male reproductive (males only) | 17 | 0.89 (0.47 - 1.31) | 0- | 1.74 | – | 2.16 |
Urinary | 16 | 0.84 (0.43 – 1.24) | 1.18 | 0.51 | 0.175 | 3.44 |